nimodipine has been researched along with Cirrhosis, Liver in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Liver fibrosis is the principal cause of morbidity and mortality in patients with iron overload." | 1.43 | Calcium channel blockers ameliorate iron overload-associated hepatic fibrosis by altering iron transport and stellate cell apoptosis. ( Chang, Y; Chu, L; Chu, X; Gao, Y; Guo, H; Liu, Z; Wang, N; Zhang, J; Zhang, X; Zhang, Y; Zhao, X, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 2 |
| Zhao, X | 1 |
| Chang, Y | 1 |
| Chu, X | 1 |
| Zhang, X | 1 |
| Liu, Z | 1 |
| Guo, H | 1 |
| Wang, N | 1 |
| Gao, Y | 1 |
| Zhang, J | 1 |
| Chu, L | 1 |
| Gengo, FM | 1 |
| Fagan, SC | 1 |
| Krol, G | 1 |
| Bernhard, H | 1 |
1 trial available for nimodipine and Cirrhosis, Liver
| Article | Year |
|---|---|
Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls.
Topics: Adult; Aged; Blood Pressure; Humans; Kinetics; Liver Cirrhosis; Metabolic Clearance Rate; Middle Age | 1987 |
1 other study available for nimodipine and Cirrhosis, Liver
| Article | Year |
|---|---|
Calcium channel blockers ameliorate iron overload-associated hepatic fibrosis by altering iron transport and stellate cell apoptosis.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Cell Line; Collagen; Deferoxamine; Diltiazem; Hepatic | 2016 |